Clustering of Cancer Cell Lines Using A Promoter- Targeted Liquid Hybridization Capture-Based Bisulfite Sequencing Approach

被引:7
|
作者
Gao, Fei [1 ]
Wang, Junwen [1 ]
Ji, Guanyu [1 ]
Liu, Siyang [1 ]
Yao, Yu [1 ]
Wang, Tong [1 ]
Wu, Honglong [1 ]
Xia, Yudong [1 ]
Gong, Desheng [1 ]
Jiang, Hui [1 ]
Yang, Huanming [1 ,2 ,3 ]
Zhang, Xiuqing [4 ]
机构
[1] BGI Shenzhen, Sci & Technol Dept, Shenzhen 518083, Peoples R China
[2] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia
[3] James D Watson Inst Genome Sci, Hangzhou, Zhejiang, Peoples R China
[4] BGI Shenzhen, Guangdong Enterprise Key Lab Human Dis Genom, Shenzhen 518083, Peoples R China
基金
中国国家自然科学基金; 国家高技术研究发展计划(863计划);
关键词
Cancer classification; CIMP; DNA methylation; Promoter; Targeted bisulfite sequencing; ISLAND METHYLATOR PHENOTYPE; GENOME-WIDE ANALYSIS; DNA METHYLATION; GENE-EXPRESSION; CPG ISLANDS; CLASSIFICATION; HYPERMETHYLATION; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; PREDICTION;
D O I
10.1177/1533034614500416
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
DNA methylation plays a significant role in assuring cell identity, thus potentiating its application in molecular classification of cancers in respect to tissue-origins or clinically and etiologically distinct subtypes. In this study, we optimized our liquid hybridization capture-based bisulfite sequencing (LHC-BS) approach on the gene promoter regions of 11 cell lines. Our results indicated that promoter methylomes could not only cluster cancer cell lines with respect to tissue origins but also differentiate cancer subtypes based on CpG island methylator phenotype (CIMP). Promoter-targeted LHC-BS as means for comprehensive screening and classifying cancer cells with promoter methylomes provided a powerful strategy for further complex clinical studies.
引用
收藏
页码:383 / 394
页数:12
相关论文
共 50 条
  • [31] Identifying a wide range of actionable variants using capture-based ultra-deep targeted sequencing in treatment-naive patients with primary lung adenocarcinoma
    Chen, Lingfeng
    Chen, Minyan
    Lin, Jie
    Chen, Xiaoyan
    Chen, Zhizhong
    Jin, Long
    Yu, Xunbin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2020, 13 (03): : 525 - 535
  • [32] NTRK1 fusion identified by capture-based next-generation sequencing in non-small-cell lung cancer.
    Zhao, Ruiying
    Xiang, Chan
    Dong, Nan
    Guo, Lianying
    Ma, Shengji
    Han, Yuchen
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Analysis of ovarian cancer cell lines using array-based comparative genomic hybridization
    Lambros, MBK
    Fiegler, H
    Jones, A
    Gorman, P
    Roylance, RR
    Carter, NP
    Tomlinson, IPM
    JOURNAL OF PATHOLOGY, 2005, 205 (01): : 29 - 40
  • [34] Comprehensive Assessment of Targetable Somatic Alterations in Cytologic Cell Block Material Using a Clinical, Hybrid Capture-Based, Next-Generation Sequencing Assay
    Sadowska, Justyna
    Zehir, Ahmet
    Benayed, Ryma
    Ladanyi, Marc
    Lin, Oscar
    Arcila, Maria
    LABORATORY INVESTIGATION, 2015, 95 : 524A - 524A
  • [35] Comprehensive Assessment of Targetable Somatic Alterations in Cytologic Cell Block Material Using a Clinical, Hybrid Capture-Based, Next-Generation Sequencing Assay
    Sadowska, Justyna
    Zehir, Ahmet
    Benayed, Ryma
    Ladanyi, Marc
    Lin, Oscar
    Arcila, Maria
    MODERN PATHOLOGY, 2015, 28 : 524A - 524A
  • [36] Use of capture-based next-generation sequencing to detect ALK fusion in plasma cell-free DNA of patients with non-small-cell lung cancer
    Cui, Shaohua
    Zhang, Wei
    Xiong, Liwen
    Pan, Feng
    Niu, Yanjie
    Chu, Tianqing
    Wang, Huimin
    Zhao, Yizhuo
    Jiang, Liyan
    ONCOTARGET, 2017, 8 (02) : 2771 - 2780
  • [37] Noninvasive genotyping and monitoring of anaplastic lymphoma kinase (ALK) rearranged non-small cell lung cancer by capture-based next-generation sequencing
    Wang, Ye
    Tian, Pan-Wen
    Wang, Wei-Ya
    Wang, Ke
    Zhang, Zhou
    Chen, Bo-Jiang
    He, Yan-Qi
    Li, Lei
    Liu, Hao
    Chuai, Shannon
    Li, Wei-Min
    ONCOTARGET, 2016, 7 (40) : 65208 - 65217
  • [38] Simultaneous multi-cancer detection and tissue of origin (TOO) localization using targeted bisulfite sequencing of plasma cell-free DNA (cfDNA)
    Oxnard, G. R.
    Klein, E. A.
    Seiden, M. V.
    Hubbell, E.
    Venn, O.
    Jamshidi, A.
    Zhang, N.
    Beausang, J. F.
    Gross, S.
    Kurtzman, K. N.
    Fung, E. T.
    Allen, B.
    Fields, A. P.
    Liu, H.
    Sekeres, M. A.
    Richards, D. A.
    Yu, P. P.
    Aravanis, A. M.
    Hartman, A-R.
    Liu, M. C.
    ANNALS OF ONCOLOGY, 2019, 30 : 912 - 912
  • [39] Application of liquid biopsy-based targeted capture sequencing analysis to improve the precision treatment of non-small cell lung cancer by tyrosine kinase inhibitors
    Zhang, Lei
    Coffin, John
    Formenti, Kim
    Chu, Quincy
    Izevbaye, Iyare
    BMJ OPEN RESPIRATORY RESEARCH, 2022, 9 (01)
  • [40] Liquid biopsy in patients with metastatic pancreatic cancer using an optimized targeted sequencing approach: Data from the pancreatic cancer registry PanDaDETECT
    Witte, David
    Czaja, Frederick
    Lugnier, Celine
    Keller, Magdalena
    Noepel-Duennebacke, Stefanie
    Ekmekciu, Ira
    Overheu, Oliver
    Schlageter, Elena
    Westphalen, C. Benedikt
    Kraeft, Anna-Lena
    Gisder, Doreen M.
    Uhl, Waldemar
    Hoehn, Philipp
    Strotmann, Johanna
    Reinacher-Schick, Anke C.
    Tannapfel, Andrea
    Christmann, Jens
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)